GC-PRO Intervention

Last updated: January 4, 2025
Sponsor: University of Minnesota
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cancer

Vascular Diseases

Treatment

Genetic counseling at months 10-15

Genetic counseling at months 14-15

Genetic counseling months 4-15

Clinical Study ID

NCT06671704
CBS-2024-33212
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of the GC-PRO study is to try to make genetic counseling better for people of all backgrounds. We are asking participants to complete two surveys and to allow audio recording of their genetic counseling visit. The purpose of the study is to understand whether trying different ways of doing genetic counseling will lead to better experiences for patients. The research team is also working with partners from the Somali, Latino/Hispanic, Black/African American, and Hmong communities to make sure the research is being done in a way that will benefit underserved communities.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Aged 18 years or older

  • individual OR their child has been referred to genetic counseling for family and/orpersonal history of hereditary cancer, cardiology condition, general geneticsindication, or reproductive/prenatal indication at a participating study site

  • understand and be able to provide information for study forms and surveys inEnglish.

Exclusion

Exclusion Criteria:

  • Unable to provide informed consent

  • For pediatric genetic counseling referrals, individuals who are not the parent orlegal guardian of the child will be excluded from participating.

Study Design

Total Participants: 994
Treatment Group(s): 6
Primary Treatment: Genetic counseling at months 10-15
Phase:
Study Start date:
January 03, 2025
Estimated Completion Date:
June 30, 2026

Connect with a study center

  • University of Minnesota

    Minneapolis, Minnesota 55414
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.